{
    "Trade/Device Name(s)": [
        "BD Respiratory Viral Panel (BD RVP) for BD MAX System",
        "BD Respiratory Viral Panel-SCV2 (BD RVP-SCV2) for BD MAX System",
        "BD Respiratory Viral Panel for BD MAXTM System",
        "BD Respiratory Viral Panel-SCV2 for BD MAXTM System"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K230956",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN200031",
        "K211079",
        "K221460"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QOF",
        "QQX"
    ],
    "Summary Letter Date": "April 4, 2023",
    "Summary Letter Received Date": "April 4, 2023",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3981"
    ],
    "Regulation Name(s)": [
        "Device To Detect And Identify Nucleic Acid Targets In Respiratory Specimens From Microbial Agents That Cause The SARS-Cov-2 Respiratory Infection And Other Microbial Agents When In A Multi-Target Test",
        "Multi-Target Respiratory Specimen Nucleic Acid Test Including SARS-CoV-2 And Other Microbial Agents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "SARS-CoV-2",
        "Influenza A",
        "Influenza B",
        "Respiratory Syncytial Virus (RSV)"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab (NPS)",
        "Anterior nasal swab (ANS)"
    ],
    "Specimen Container(s)": [
        "BD Universal Viral Transport System (UVT)",
        "Copan Universal Transport Media System (UTM)",
        "BD Molecular RVP Sample Buffer Tube (SBT)"
    ],
    "Instrument(s)/Platform(s)": [
        "BD MAX System"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplexed real-time reverse transcriptase polymerase chain reaction (RT-PCR)",
        "Paired reporter and quencher fluorescence labeled probes (TaqMan Technology)"
    ],
    "Methodologies": [
        "Automated sample preparation",
        "Target lysis",
        "Total Nucleic Acid (TNA) extraction and concentration",
        "Hydrolysis probe-based real-time PCR"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Panel",
        "Automated system",
        "Reagent",
        "Cartridge",
        "Consumable",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for BD Respiratory Viral Panel and BD Respiratory Viral Panel-SCV2 for BD MAX System\u2014multiplexed RT-PCR assay for qualitative detection of SARS-CoV-2, Influenza A, Influenza B, and RSV in nasopharyngeal and anterior nasal swab specimens",
    "Indications for Use Summary": "Qualitative multiplex detection of SARS-CoV-2, Influenza A, Influenza B, and RSV nucleic acid in nasopharyngeal and anterior nasal swabs from individuals with signs/symptoms of respiratory infection; aids differential diagnosis when used with other clinical information",
    "fda_folder": "Microbiology"
}